Acer Therapeutics Inc.

CIK 1069308 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acer Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Nov 30, 202315-12G0001193125-23-285670
Nov 24, 2023EFFECT9999999995-23-003428
Nov 24, 2023EFFECT9999999995-23-003427
Nov 20, 2023S-8 POS0001193125-23-280714
Nov 20, 202340000899243-23-020439
Nov 20, 2023POS AM0001193125-23-280689
Nov 20, 202340000899243-23-020441
Nov 20, 202310-Q0000950170-23-065159
Nov 20, 202340000899243-23-020443
Nov 20, 2023POS AM0001193125-23-280687
Nov 20, 2023S-8 POS0001193125-23-280700
Nov 20, 2023S-8 POS0001193125-23-280708
Nov 20, 2023S-8 POS0001193125-23-280696
Nov 20, 20238-K0001193125-23-280679
Nov 20, 202325-NSE0001354457-23-000878
Nov 20, 2023S-8 POS0001193125-23-280705
Nov 20, 202340000899243-23-020440
Nov 20, 2023S-8 POS0001193125-23-280698
Nov 20, 2023S-8 POS0001193125-23-280711
Nov 20, 2023S-8 POS0001193125-23-280712
Nov 20, 202340000899243-23-020445
Nov 20, 2023S-8 POS0001193125-23-280707
Nov 20, 202340000899243-23-020438
Nov 20, 2023S-8 POS0001193125-23-280702
Nov 20, 2023S-8 POS0001193125-23-280692